HMS Sepsis – How a State-Wide Quality Collaborative Facilitates Performance Improvements and Collaboration

HMS Sepsis – How a State-Wide Quality Collaborative Facilitates Performance Improvements and Collaboration

4.94 (36 votes)

Description: 

The Michigan Hospital Medicine Safety Consortium (HMS) is a data-driven collaborative supported by Blue Cross and Blue Shield of Michigan. HMS provides the infrastructure needed to facilitate data collection and information sharing to support Michigan hospitals in improving the safety and quality of care for hospitalized medical patients. In 2021, HMS launched a sepsis initiative among 12 volunteer pilot hospitals. In 2022, the sepsis initiative was launched among the remaining 57 HMS hospitals. The HMS sepsis initiative assesses the care of patients meeting surveillance criteria for sepsis with the goal of improving patient experience and outcomes across the continuum of care – from early identification and management to post-discharge care coordination and 90-day outcomes.

The presentation will begin with Dr. Prescott introducing participants to HMS and discussing why HMS and Blue Cross and Blue Shield of Michigan identified sepsis as a priority for Michigan hospitals. HMS data provided to participating sites will be reviewed with examples of how sites are utilizing the data, tools, and resources provided by HMS to drive quality improvement and education at their sites. Following Dr. Prescott’s presentation will be a panel session that engages HMS physicians, BCBSM leadership, a Sepsis Quality Improvement Consultant, and a physician representative from an HMS participating site.

Learning Objectives: 

At the end of the activity, the learner should be able to:

  • Summarize the processes and infrastructure provided by HMS Sepsis to facilitate quality improvement and collaborations across Michigan hospitals;
  • Restate the wide differences in sepsis practice across Michigan sites that result in variance in success rates for performance metrics;   
  • Identify the various interventions sites have taken to implement quality improvement work for management of patient with sepsis;
  • Summarize how various members of quality collaboratives work together to create mutually beneficial relationships.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Webinar Supporter: 

Sepsis Alliance gratefully acknowledges the support provided by the Sepsis Alliance Institute Sponsor.

image

Hallie Prescott, MD, MSc

Associate Professor of Internal Medicine Division of Pulmonary Critical Care

University of Michigan

Hallie Prescott, MD, MSc, is an Associate Professor of Internal Medicine in the Division of Pulmonary Critical Care within Michigan Medicine and a Staff Physician at the Ann Arbor Veterans Affairs Medical Center. She is the physician lead on the HMS Sepsis and Mi-COVID19 Initiatives. Hallie completed medical school, residency, and chief residency at Ohio State University, and fellowship and Masters in Health Services Research at the University of Michigan. She is interested in sepsis, performance measurement, and long-term outcomes after critical illness. She serves as Vice-Chair of the Surviving Sepsis Campaign Guidelines, as a council member of the International Sepsis Forum, and on the advisory board of Sepsis Alliance.

Pat Posa RN, BSN, MSA, CCRN-K, FAAN

Quality and Patient Safety Program Manager

UH/CVC, Michigan Medicine

Pat Posa RN, BSN, MSA, CCRN, FAAN, is the Quality and Safety Program Manager for the Hospital Medicine Safety Consortium (HMS), providing clinical oversight for their quality improvement work. Before that, she was the Quality and Patient Safety Program Manager for the Adult Hospitals at Michigan Medicine. In her role, she was responsible for the development, measurement, and sustainability of the Adult Hospitals’ Quality and Patient Safety program. Pat was previously a Quality Excellence Leader for St. Joseph Mercy Health System in Southeastern Michigan, leading initiatives to reduce hospital-acquired conditions, improve patient outcomes for critically ill patients, and reduce readmissions.

She received her Bachelor of Science in Nursing from Wayne State University and her Masters in Administration from Central Michigan University. Pat has a strong interest in sepsis and critical care. In her 44 years of practice, Pat has held various roles in healthcare in the hospital, ambulatory setting, and health plans, including manager of inpatient critical care units, Director of Nursing, and administrator of an outpatient multispecialty/primary care clinic.

Pat has been involved in many quality and patient safety programs, such as hospital and system-wide sepsis management programs and a statewide Keystone ICU patient safety initiative. She has been faculty for multiple state and national clinical collaboratives including the Surviving Sepsis Campaign Phase IV Collaborative, the national project on Comprehensive Unit Safety Program (CUSP) for Mechanically Ventilated Patients, and the Society of Critical Care Medicine’s ICU Liberation Collaborative. Pat has been a member and co-chair of SCCM’s ICU Liberation Committee. Through Pat’s leadership, St. Joseph Mercy Hospital was awarded the HHS/Critical Care Societies Outstanding Leadership in Eliminating CLABSI and VAP in 2011. She was inducted as a fellow into the American Academy of Nursing in 2013. Pat was also awarded the Michigan Hospital Association Quality and Patient Safety Leadership Award in 2017. Pat has published many articles in both clinical and quality journals. She lectures and consults extensively nationally on sepsis, various critical care topics, patient safety, and quality topics.

Scott Flanders, MD

Chief Clinical Strategy Officer

Michigan Medicine

Scott A. Flanders, MD, is currently Chief Clinical Strategy Officer for Michigan Medicine, where in partnership with the Chief Strategy Officer, he leads the Department of Strategy and is responsible for the organization’s clinical growth strategy and for developing and operationalizing Michigan Medicine’s growing statewide network. Dr. Flanders is a Professor of Medicine in the Division of Hospital Medicine at the University of Michigan, where he serves as Vice Chair for the Department of Internal Medicine. He was the founding leader of Michigan’s Hospital Medicine Program, and from 2003-2017 grew the program from four faculty to over 100, while concurrently developing robust clinical, educational, quality and research programs within the section.

Dr. Flanders was a founding member of the Board of Directors of the Society of Hospital Medicine (SHM) and is a Past-President of SHM. In 2013, Dr. Flanders was awarded the designation of Master in Hospital Medicine by the Society of Hospital Medicine.

Dr. Flanders’ research interests include hospitalists, hospital-acquired conditions and their prevention, dissemination of patient safety and quality improvement practices, and the diagnosis and treatment of lower respiratory infections. Dr. Flanders developed and leads the Michigan Hospital Medicine Safety (HMS) Consortium, focused on preventing adverse events in hospitalized patients. He has authored over 200 journal articles and book chapters and has edited two textbooks and a book series in the field of Hospital Medicine. Dr. Flanders received his Medical Degree from the University of Chicago Pritzker School of Medicine and completed his residency and chief residency at the University of California, San Francisco.

Megan Cahill, DO, MBA

Division Chief of Medicine

Henry Ford Macomb Hospital

Megan Cahill, DO, MBA, is a distinguished healthcare leader and the Division Chief of Medicine at Henry Ford Macomb Hospital, leading over 750 physicians and Advanced Practice Providers across 20 medicine specialties. With a servant leadership style, she excels in navigating complex decisions, fostering team collaboration, and adapting to change. As an Emergency Medicine physician, Dr. Cahill is well-versed in sepsis management and began her leadership journey overseeing the Sepsis Steering Committee as the Sepsis Improvement Physician Champion. This passion for enhancing clinical management of sepsis and improving patients’ lives sparked further quality improvement work in antimicrobial stewardship, diagnostic stewardship, hospital-acquired infections, and vascular access devices. Recognized for leadership in education, patient safety, and professional advocacy, Dr. Cahill's multifaceted expertise serves her larger vision for continuous advancements in healthcare nationwide.

Amy McKenzie, MD, MBA

Vice President, Clinical Partnerships and Associate CMO

Blue Cross Blue Shield of Michigan

Amy McKenzie, MD, MBA is a board-certified family medicine physician with 13 years of experience in private practice and over ten years of experience in healthcare administration and clinical leadership. Dr. McKenzie joined Blue Cross Blue Shield of Michigan in 2013 as a physician consultant supporting Quality Management and Accreditation and is now the Associate Chief Medical Officer and Vice President leading Clinical Partnerships. Her team is responsible for providing clinical leadership for provider value-based programs and risk contracting and helps to enable and support the network through education, communication, and partnering on practice transformation efforts. She also leads the Behavioral Health Strategy and Planning team responsible for development and implementation of the BH strategy. Dr. McKenzie graduated from Northeast Ohio Medical University and completed her residency at Ascension Providence Hospital in Southfield, Michigan. In 2017, she received her MBA with a focus in medical management from the University of Massachusetts Amherst. She is currently serving as Vice Chair on the State of Michigan Certificate of Need Commission and is a past president on the Family Medicine Foundation of Michigan.

Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.8 contact hours.

Other healthcare professionals will receive a certificate of attendance for 1.5 contact hours.

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Components visible upon registration.